journal article·2026-06Open access

Platelet–biomimetic nanoplatforms based on sonodynamic/anti-inflammatory synergy for the prevention of vascular hyperplasia

Yang Xu, Jinfa Ye, Xinyue Wang, Jiacheng Ma, Xiaolong Sun, Yang Qin, Yun Han, Huiping Huang, Peiyu Wang, Gang Liu, Chengchao Chu, Jingsong Mao

Abstract

Vascular hyperplasia-induced stenosis remains a critical challenge in peripheral artery disease (PAD) management, often arising after stent placement or balloon angioplasty. The pathogenesis involves macrophage infiltration and smooth muscle cell proliferation, which drive neointimal formation. To address this, we engineered a targeted nano-delivery platform combining sonodynamic therapy (SDT) with our constructed ZTZTMOF nanoparticles. The ZTZTMOF nanoparticles were synthesized via coordination between [Ti 8 Zr 2 O 12 (COO) 16 ] clusters and zinc tetra(4-carboxyphenyl) porphyrin (Zn-TCPP), which could enable the energy transfer from clusters to Zn-TCPP and enhanced SDT efficiency. Afterwards, the platelet membrane nanovesicle was modified on the surface of ZTZTMOF nanoparticles, preparing vascular hyperplasia targeting ZTZTMOF@PM. In vitro and in vivo studies demonstrated that ZTZTMOF@PM-SDT significantly inhibited pathological cell proliferation. This synergistic approach offers a potential adjunct therapy to standard PAD interventions for preventing restenosis.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Ultrasound and Hyperthermia Applications · Nanoplatforms for cancer theranostics · Gold and Silver Nanoparticles Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (46)

Show source-provided references
1. Peripheral artery disease
2. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis10.1016/S0140-6736(13)61249-0 ↗
3. Peripheral artery disease: epidemiology and global perspectives10.1038/nrcardio.2016.179 ↗
4. Classification and clinical impact of restenosis after femoropopliteal stenting10.1016/j.jacc.2011.09.036 ↗
5. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the zilver PTX randomized and single-arm clinical studies10.1016/j.jacc.2013.03.034 ↗
6. Oxidized low-density lipoprotein-induced apoptosis10.1016/S1388-1981(02)00343-8 ↗
7. Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons from knockout mice10.1097/00041433-200104000-00011 ↗
8. Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis10.1038/29788 ↗
9. The mechanisms of restenosis and relevance to next generation stent design10.3390/biom12030430 ↗
10. MFN2 prevents neointimal hyperplasia in vein grafts via destabilizing PFK110.1161/CIRCRESAHA.122.320846 ↗
11. Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits10.1161/01.CIR.0000023532.98469.48 ↗
12. Therapeutic strategies to deplete macrophages in atherosclerotic plaques10.1111/j.1365-2125.2012.04211.x ↗
13. Micro/nanoparticle‐augmented sonodynamic therapy (SDT): breaking the depth shallow of photoactivation10.1002/adma.201602012 ↗
14. Natural 5-aminolevulinic acid: sources, biosynthesis, detection and applications10.3389/fbioe.2022.841443 ↗
15. Metal–ligand coordination nanomaterials for biomedical imaging10.1021/acs.bioconjchem.9b00642 ↗
16. Nanoparticles of metal‐organic frameworks: on the road to in vivo efficacy in biomedicine
17. Ultrathin Cu-TCPP MOF nanosheets: a new theragnostic nanoplatform with magnetic resonance/near-infrared thermal imaging for synergistic phototherapy of cancers10.7150/thno.25433 ↗
18. [Ti8Zr2O12 (COO)16] cluster: an ideal inorganic building unit for photoactive metal–organic frameworks10.1021/acscentsci.7b00497 ↗
19. Ligand engineering in lanthanide‐titanium‐oxo clusters: preventing charge transfer to TiIV for high‐efficiency emission
20. Nanoscale hematoporphrin-based frameworks for photo-sono synergistic cancer therapy via utilizing Al (III) as metal nodes rather than heavy metals10.1016/j.jcis.2022.02.040 ↗
21. Electronic origins of photocatalytic activity in d0 metal organic frameworks10.1038/srep23676 ↗
22. Self-organization of zinc ions with a photosensitizer in vivo for enhanced antibiofilm and infected wound healing10.1039/D2NR01404A ↗
23. Inhibition of heme oxygenase activity using a microparticle formulation of zinc protoporphyrin in an acute hemolytic newborn mouse model10.1038/pr.2015.207 ↗
24. Enhanced electrochemiluminescence of porphyrin-based metal–organic frameworks controlled via coordination modulation10.1021/acs.analchem.9b04104 ↗
25. Acid‐responsive bacteria‐targeted zinc‐porphyrin based sonosensitizer with enhancing antibacterial efficacy and biofilm eradication for infected wounds healing
26. Reactive oxygen species-activated self-amplifying prodrug nanoagent for tumor-specific Cu-chelate chemotherapy and cascaded photodynamic therapy10.1016/j.biomaterials.2022.121513 ↗
27. One responsive stone, three birds: mn (III)‐Hemoporfin frameworks with glutathione‐enhanced degradation, MRI, and sonodynamic therapy10.1002/adhm.202001463 ↗
28. State of the art advancements in sonodynamic therapy (SDT): metal-organic frameworks for SDT10.1016/j.cej.2022.137889 ↗
29. A new era of LMCT: leveraging ligand-to-metal charge transfer excited states for photochemical reactions10.1039/D3SC05268K ↗
30. Recent advances in biomimetic aggregation‐induced emission photosensitizers for photodynamic therapy and immunotherapy10.1002/bmm2.12076 ↗
31. A biomimetic, triggered‐release micelle formulation of methotrexate and celastrol controls collagen‐induced arthritis in mice (4/2024
32. Platelet membrane-coated nanocarriers targeting plaques to deliver anti-CD47 antibody for atherosclerotic therapy10.34133/2022/9845459 ↗
33. Recent advances in drug eluting stents10.1016/j.ijpharm.2012.10.029 ↗
34. Gene therapy targeting nuclear factor-κB: towards clinical application in inflammatory diseases and cancer10.2174/156652309788488569 ↗
35. Small-nucleic-acid-based therapeutic strategy targeting the transcription factors regulating the vascular inflammation, remodeling and fibrosis in atherosclerosis10.3390/ijms160511804 ↗
36. The role of IL-1 in the pathogenesis of heart disease10.1007/s00005-009-0024-y ↗
37. Inflammatory events in a vascular remodeling model induced by surgical injury to the rat carotid artery10.1038/sj.bjp.0706472 ↗
38. Smooth muscle–selective inhibition of nuclear Factor‐κB attenuates smooth muscle phenotypic switching and neointima formation following vascular injury10.1161/JAHA.113.000230 ↗
39. Early modulation of macrophage ROS-PPARγ-NF-κB signalling by sonodynamic therapy attenuates neointimal hyperplasia in rabbits10.1038/s41598-020-68543-9 ↗
40. Inflachromene inhibits intimal hyperplasia through the HMGB1/2-regulated TLR4-NF-κB pathway10.1016/j.intimp.2023.110198 ↗
41. Osthole inhibits intimal hyperplasia by regulating the NF-κB and TGF-β1/Smad2 signalling pathways in the rat carotid artery after balloon injury10.1016/j.ejphar.2017.06.025 ↗
42. Comprehensive proteomic analysis of mesenchymal stem cell exosomes reveals modulation of angiogenesis via nuclear factor-kappaB signaling10.1002/stem.2298 ↗
43. Nanoanalytical insights into the stability, intracellular fate, and biotransformation of metal–organic frameworks10.1021/acsami.3c08818 ↗
44. Biocompatibility and biodegradability of metal organic frameworks for biomedical applications10.1039/D1TB01044A ↗
45. Zinc-based metal–organic frameworks as nontoxic and biodegradable platforms for biomedical applications: review study10.1080/03602532.2019.1632887 ↗
46. Metabolic derangement of essential transition metals and potential antioxidant therapies10.3390/ijms25147880 ↗